Target intelligence / Profile preview

TUBA1C antisense RNA 1 (TUBA1C-AS1)

Target: TUBA1C-AS1
Molecular classification: Long noncoding RNA (lncRNA), Other

Overview

TUBA1C antisense RNA 1 (TUBA1C-AS1) is presumed to be a long noncoding RNA transcribed from the antisense strand of the TUBA1C locus. Unlike TUBA1C (which encodes a tubulin alpha chain involved in cell cycle progression and cancer biology), TUBA1C-AS1 has not been substantially described in the scientific literature, and there is little evidence supporting its role as a therapeutic target or biomarker. Its molecular function, disease relevance, and pharmacological interactions remain undefined in current public datasets and published studies.

Mechanism of action

None established; no drugs or experimental compounds reported to target TUBA1C-AS1.

Biological functions

Unknown

Disease associations

Unknown

Beyond the preview

Go deeper on TUBA1C antisense RNA 1 (TUBA1C-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TUBA1C antisense RNA 1 (TUBA1C-AS1).

Explore the full profile